A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group.
- Citation:
- Urology vol 69 (2) 289-94
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA-15083, CA-25224, CA-35101, CA-35103, CA-35113, CA-35119, CA-35195, CA-35267, CA-35269, CA-37404, CA-37417, CA-52352, CA-60276, CA-63826
- Corr. Author:
- Authors:
- Aminah Jatoi Patrick Burch David Hillman Joanne M Vanyo Shaker Dakhil Daniel Nikcevich Kendrith Rowland Roscoe Morton Patrick J Flynn Charles Young Winston Tan
- Networks:
- Study
- NCCTG-N0351
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Administration, Oral, Aged, Aged, 80 and over, Androgens, Anticarcinogenic Agents, Biopsy, Needle, Carotenoids, Complementary Therapies, Dietary Supplements, Follow-Up Studies, Humans, Lycopersicon esculentum, Male, Middle Aged, Neoplasm Staging, Neoplasms, Hormone-Dependent, Patient Selection, Probability, Prostate-Specific Antigen, Prostatic Neoplasms, Risk Assessment, Treatment Outcome